Adam Raymakers

Interested in how climate impact could be incorporated into health technology assessment? We leverage real-world evidence for triple therapy inhalers, estimates of the carbon footprint on inhalers, and bring it together in an HTA framework! #ISPORAnnual

Just out! Our new paper in @jamadermatology.com investigating the budget impact of Vyjuvek and Zevaskyn in recessive dystrophic epidermolysis bullosa.

Happy to share that I've joined the Editorial Board of the Journal of Cancer Policy as a Section Editor. Really excited to be part of the journal, work with the editorial board, and engage with authors submitting their research! sciencedirect.com/journal/jour...

It's been a few years but really excited to be back at Canada's Drug Agency Symposium 2026! Off to a great start with a plenary on international approaches to HTA with Suzanne McGurn, Sarah Emond, Natalie M., and Yannis Natsis. #CDAAMC26

Two abstracts accepted for ISPOR 2026 in Philadelphia! The 1st abstract illustrates a way to include climate impact into health technology assessment. The 2nd is an analysis of spending on new gene therapies for recessive dystrophic epidermolysis bullosa. See you in Philly!

The FDA is increasingly turning to ad hoc expert panels instead of federal advisory committees for external advice. FDA watchers generally agree these expert panels "are likely unlawful," USC Schaeffer's @profgenkanter.bsky.social tells Regulatory Focus.

New paper just out! Led by Arianna Gentilini and @leah-rand.bsky.social, we performed a systematic review of studies investigating COI in FDA advisory committee meetings. Full article (in press) here: www.valueinhealthjournal.com/article/S109...

We would like to recruit a stellar junior faculty member in the Division of Child Health Research and Policy @deptpopmed.bsky.social at Harvard. Please circulate this announcement widely! www.populationmedicine.org/divisions-ce...

New paper just out! Led by Arianna Gentilini and @leah-rand.bsky.social, we performed a systematic review of studies investigating COI in FDA advisory committee meetings. Full article (in press) here: www.valueinhealthjournal.com/article/S109...

Really interesting new article by Kaparis et al from @pennmedicine.bsky.social providing an overview of the current barriers/facilitators to accessing CAR-T therapy. sciencedirect.com/science/arti...

East coast fall. #capebretonisland

Some more @cnn.com coverage of our study, led by @wbfeldman.bsky.social, on greenhouse gas emissions associated with inhaler use in the US.

Happy to see that @cnn.com picked up our @jama.com on greenhouse gas emissions and inhaler usage in the US. Original article: jamanetwork.com/journals/jam... www.cnn.com/2025/10/06/h...

Really excited to share, and happy have been a part of, this new paper led by @wbfeldman.bsky.social out today in @jama.com! We conducted a comprehensive analysis of greenhouse gas emissions associated with inhaler usage in the US. Read it here: jamanetwork.com/journals/jam...

New edition of the PORTAL Post (the @portalresearch.org monthly newsletter), featuring lots of great research, including our recent publication about modelling the budget impact of gene therapies to treat sickle cell disease in the US. Check it out here: www.linkedin.com/pulse/octobe...

The Common Sense Oncology Fellowship program is now accepting applications. Definitely a great opportunity for anyone interested in health services research and oncology! commonsenseoncology.org/wp-content/u...

Annual trip home to the cottage! #CapeBretonIsland

'The FDA will ask Sarepta to stop shipping its Duchenne muscular dystrophy treatment Elevidys, an HHS official said, in what could be a final blow to the company’s hopes for the product following two patients’ deaths.' via @endpts.com endpoints.news/fda-asks-sar...

'Drugmakers [said] they were stockpiling drugs in the US as a strategy to curb the impact of potential pharma tariffs. In March, Ireland saw a massive 243% increase in pharma exports, compared to the same month last year.' via @annajbrown.bsky.social / @endpts.com endpoints.news/pharmaceutic...

Fantastic postdoc fellowship opportunity @mcgill.ca! mcgill.wd3.myworkdayjobs.com/McGill_Caree...

Always a super interesting read! Notably, amongst the top 20 CEOs, average compensation was greater than $30 million. Total compensation for the top 20 CEOs was more than $600,000,000. Also notable that there is only one woman amongst the top 20. via @andrewedunn.bsky.social / @endpts.com

Just out! The new guidelines from the Canadian Patented Medicine Prices Review Board (PMPRB) have finally been released. Changes to take effect as of January 2026. #hta #drugprices www.canada.ca/en/patented-...

New Health Affairs Forefront by @akesselheim.bsky.social and @jerryavorn.bsky.social from @portalresearch.org about the impact of tariffs on the affordability and availability of medications. www.healthaffairs.org/content/fore...

A little work to make one of the local #Squamish trails a bit more friendly to those riding adaptive mountain bikes.

New in @jama.com, Joseph Daval and I discuss legal issues surrounding ACIP including its role in setting government policy and dealing with politically-motivated agendas arising from its new membership: jamanetwork.com/journals/jam...

The clinical aspect & decision aside, it's problematic for health systems that BioMarin priced Brineura at $1 million. If companies didn't charge these prices, decisions would be easier & less restrictive. Note: Brineura's net sales in 2024 were $170 million (US alone). www.cbc.ca/news/canada/...

'A 2023 analysis of more than 20 million deaths across the world found that hot days and days with bad air quality both resulted in higher-than-normal mortality rates. But periods in which heat and pollution are combined were even more deadly.' via @nytimes.com

Looking for a recent paper that reports on HRQoL via EQ-5D-5L/3L scores, that specifically reports on the each of the domains/levels of the EQ-5D. Preferably in a chronic disease, and also preferably US-based (but not necessary). Anyone? @euroqol.bsky.social #healtheconomics #hspr #QALYs

Our special issue, “Advancing Trust in Science: Institutional Obligations to Promote Research Integrity,” is now live in @jlme-journal.bsky.social. Check out the full line up of leading voices on spotting, addressing, and preventing misconduct. www.cambridge.org/core/journal...

I've attended this event in the past and it's absolutely fantastic! Not to mention Galway is an incredibly fun city to visit. Highly recommend!

Added a few more folks recently so thought I'd re-share. If I've missed you, reach out and I'll add you to the list! #healtheconomics

Super interesting story about Novo Nordisk and their Canadian patents. '... Novo did file a patent there for semaglutide. . .but the last time they paid the annual maintenance fee on it was 2018!' by @dereklowe.bsky.social www.science.org/content/blog...

Great and engaging panel discussion about the future of the Inflation Reduction Act by @benro.me and Chris Cai (both from @portalresearch.org), @dusetzinas.bsky.social (Vanderbilt Health Policy), and Alyson Bancroft (@p4ad.bsky.social)! #ARM25

Presenting some work on spending associated with drugs for ultra-rare diseases at the @academyhealth.bsky.social Annual Research Meeting! #arm25 @portalresearch.org

Chris Cai from @portalresearch.org presenting on private equity acquisitions of health care delivery organizations at the @academyhealth.bsky.social Annual Research Meeting. #arm25

Opening plenary underway with @aaronecarroll.bsky.social at the @academyhealth.bsky.social Annual Research Meeting. #arm25

Opening plenary underway with @aaronecarroll.bsky.social at the @academyhealth.bsky.social Annual Research Meeting. #arm25

On my way to the Academy Health (@academyhealth.bsky.social) Annual Research Meeting in Minneapolis with @jerryavorn.bsky.social in my ear! #arm2025 @portalresearch.org

Looking forward to attending my first ever Academy Health Annual Research Meeting with fellow @portalresearch.org members @benro.me and Chris Cai! I'll be presenting some work on spending associated with drugs for ultra-rare diseases on Sunday. See you there! #arm2025 @academyhealth.bsky.social

Great talk today by Dr Beate Sander at the annual Vancouver Health Economics Methodology Meeting on economic evidence as a component of public health decision making, with lots of discussion about the societal perspective! #healtheconomics #hta

Lots of great work showcased in this month's newsletter from @portalresearch.org! www.linkedin.com/pulse/june-2...

Just out! Sharing some new research led by @hmctaggartcowan.bsky.social from @sfu-fhs.bsky.social and BC Cancer that I was involved with. We used a discrete choice experiment to elicit patient preferences for physiotherapy services post-surgery for breast cancer. academic.oup.com/ptj/advance-...

Nice night out there.